Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma

Immunohistochemistry for Claudin-4 and BAP1 in the Differential Diagnosis between Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma

(2023) Lina Zuccatosta et al.   Diagnostics

New developments in mesothelial pathology

(2023) Andrew Churg   HISTOPATHOLOGY

Hypothesis: HEG1 and claudin‐4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus  non‐small ‐cell lung carcinoma with only two stains in most cases

(2022) Andrew Churg et al.   HISTOPATHOLOGY

Distinct Uroplakin II Staining Pattern in Apocrine Breast Carcinoma

(2022) Derek M. van Pel et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells

(2022) Maximilian Lennartz et al.   Diagnostics

Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma

(2021) Julia R. Naso et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

HEG1 is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma

(2020) Julia R. Naso et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

(2018) Aliya Noor Husain et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE